Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MTS Imipenem-relebactam 0.002/4-32/4 µg/mL

K-Number: K191809 · 2019-08-23

Decision Date2019-08-23
Product CodeJWY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

MTS Imipenem-relebactam 0.002/4-32/4 µg/mL is a medical device manufactured by Liofilchem s.r.l.. It received FDA 510(k) clearance on 2019-08-23 under approval number K191809. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MTS Imipenem-relebactam 0.002/4-32/4 µg/mL?

MTS Imipenem-relebactam 0.002/4-32/4 µg/mL is a medical device that received FDA 510(k) clearance on 2019-08-23. It is manufactured by Liofilchem s.r.l.. The 510(k) number is K191809.

When was MTS Imipenem-relebactam 0.002/4-32/4 µg/mL approved by the FDA?

MTS Imipenem-relebactam 0.002/4-32/4 µg/mL received FDA 510(k) clearance on 2019-08-23, under approval number K191809.

What company makes MTS Imipenem-relebactam 0.002/4-32/4 µg/mL?

MTS Imipenem-relebactam 0.002/4-32/4 µg/mL is manufactured by Liofilchem s.r.l..

What is the FDA product code for MTS Imipenem-relebactam 0.002/4-32/4 µg/mL?

The FDA product code for MTS Imipenem-relebactam 0.002/4-32/4 µg/mL is JWY.

Other Devices by Liofilchem s.r.l.

View all 35 devices →

Related Devices (Code: JWY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.